AndreaElisabethWahner HendricksonMD

PubMed

• 110 citations
  Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2)
  Elizabeth M. Swisher, Tanya T. Kwan, Amit M. Oza, Anna V. Tinker, Isabelle Ray-Coquard
  Nature Communications. 2021-05-03
• 20 citations
  Characterization of a RAD51C-silenced high-grade serous ovarian cancer model during development of PARP inhibitor resistance
  Rachel M. Hurley, Cordelia D. McGehee, Ksenija Nesic, Cristina Correia, Taylor M. Weiskittel
  NAR Cancer. 2021-07-02
• 54 citations
  53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer
  Rachel M. Hurley, Andrea E. Wahner Hendrickson, Daniel W. Visscher, Peter Ansell, Maria I. Harrell
  Gynecologic Oncology. 2019-04-01

Journal Articles

• Oncologic emergencies  
  Behl D, Hendrickson AW, Moynihan TJ, Crit Care Clin, 1/1/2010
• Insulin Receptor A and IGF-1R in AML  
  Wahner Hendrickson A, Haluska P, Erlichman C, Gottardis M, Karp JE, Carboni JM Kaufmanm SH, Cancer Res, 1/1/2010
• Insulin Receptor A and IGF-IR in AML-Response  
  Wahner-Hendrickson AE, Haluska P, Erlichman C, Gottardis M, Carboni JE, Karp JE, Kaufmann SH, Cancer Res, 1/1/2010
• Anticancer therapy: boosting the bang of Bim  
  Hendrickson AW, Meng XW, Kaufmann SH, J Clin Invest, 1/1/2008
• Porcine endothelial cells and iliac arteries transduced with AdenoIL-4 are intrinsically protected, through Akt activation, against immediate injury caused by human co...  
  Black SM, Grehan JF, Rivard AL, Benson BA, Wahner AE, Koch AE, Levay-Young BK, Dalmasso AP, J Immunol, 1/15/2006
• Progression of chronic myeloid leukemia to blast crisis during treatment with imatinib mesylate  
  Xu Y, Wahner AE, Nguyen PL, Arch Pathol Lab Med, 1/1/2004
• Bispecific antibody-targeted phagocytosis of HER-2/neu expressing tumor cells by myeloid cells activated in vivo  
  Wallace PK, Kaufman PA, Lewis LD, Keler T, Givan AL, Fisher JL, Waugh MG, Wahner AE, Guyre PM, Fanger MW, Ernstoff MS, J Immunol Methods, 1/1/2001
• Human monocytes express CD163, which is upregulated by IL-10 and identical to p155  
  Sulahian TH, Hogger P, Wahner AE, Wardwell K, Goulding NJ, Sorg C, Droste A, Stehling M, Wallace PK, Morganelli PM, Guyre PM, Cytokine, 1/1/2000
• The role of CD8+ CD40L+ T cells in the formation of germinal centers in rheumatoid synovitis  
  Wagner UG, Kurtin PJ, Wahner A, Brackertz M, Berry DJ, Goronzy JJ, Weyand CM, J Immunol, 1/1/1998
• Join now to see all

Books/Book Chapters

• Mayo Clinic Internal Medicine Board Review 
  Chapter: Cervical, Endometrial, Ovarian Cancers. 
  Wahner Hendrickson AEEdition 11th,2014
• Innovative Leukemia and Lymphoma Therapy 
  Chapter: mTOR targeting agents for the treatment of lymphoma and leukemia. 
  Page 525 - 538Wahner Hendrickson AE, Witzig TE, Kaufmann SHEditors: Kaspers GJL, et al.Informa Healthcare, New York2008

Abstracts/Posters

• The role of CHFR Expression in Ovarian Cancer and Response to Therapy.
  Wahner Hendrickson A, Visccher D, Goergen K, Negron V, Lingle W, Oberg A, Kalli K, Hartmann L, Maurer M, Kaufmann S, Journal of Clinical Oncology, 1/1/2013
• Dual inhibition of mTORC1/mTORC2 induces apoptosis of mantle cell lymphoma by preventing Rictor mediated AKT(S413) phosphorylation by potentiating AKT2 PHLPP1 associat...
  Gupta M, Wahner Hendrickson A, Han JJ, Stenson M, Wellik L, Barr S, Kaufmann SH, Witzig TE, Blood, 1/19/2010
• OSI 027, a Dual TORC1/TORC2 inhibitor, induces bim and puma mediated apoptosis in lymphoid malignancy.
  Wahner Hendrickson AE, Gupta M, Yun S, Shing JC, Schneider PA, Peterson KL, Karp JE, Barr S, Witzig TE, Kautmann SH, Blood, 1/19/2010
• Apoptotic and Anti-Proliferative Effects of the Dual Insulin-Like Growth Factor-1/Insulin Receptor Inhibitor, BMS 536924 in Acute Myelogenous Leukemia.
  Andrea E. Wahner Hendrickson, MD, American Association for Cancer Research, Los Angeles, CA, 1/1/2007
• Apoptotic and Anti-Proliferative Effects of the Daul Insulin-Like Growth Factor-1 (IGF-1R)/Insulin Receptor Inhibitor, BMS 536924, in Acute Myelogenous Leukemia.
  Wahner HA, Karp JE, Attar RM, Smith DB, Wittman M, Gottardis M, Haluska P, Kaufmann SH, Proceedings of the American Association for Cancer Research, 1/1/2007
• IL-4 and IL-13 Gene Transfer in Porcine Endothelial Cells Induce Cytokine Production and Protection from Apoptosis and Human Complement.
  Andrea E. Wahner Hendrickson, MD, American College of Physicians Annual Session, 1/1/2004
• IL-4 and IL-13 Gene Transfer in Porcine Endothlia Cells Induce Cytokine Protection and Protection from Apoptosis and Human Complement.
  Wahner A, Grehan J, Benson A, Koch B, Levay-Young B, Dalmasso A, Minnesota Medicine, 1/1/2004
• Progression of Chronic Myeloid Leukemia from Chronic Phase to Blast Crisis During Treatment with Imatinib Mesylate: A Report of Three Cases.
  Xu Y, Wahner AE, Nguyen PL, Modern Pathology, 1/1/2004
• IL-4 and IL-13 induce gene protection of porcine endothelial cells from complement medicated killing through activation of the Pl3 kinase/AKT pathway.
  Grehan J, Wahner A, Benson A, Koch B, Levay-Young B, Dalmasso A, Xenotransplantation, 1/1/2003
• Join now to see all

Lectures

• Clinical Pearls: Infectious Diseases and Oncology 
  2019 ACP Internal Medicine Meeting, Philadelphia - 4/12/2019
• "Brief Overview of Gynecologic Oncology" 
  Rochester, MN, 2013-2014 - 1/1/2015
• "Gynecologic Malignancies" 
  Lima, Peru - 1/1/2014
• "International Collaborations to Advance Treatments of Ovarian Cancer" 
  1/1/2014
• "Insulin Receptor Isoform Expression in Ovarian Cancer in African American Women" 
  Tampa, FL - 1/1/2014
• "Chemotherapy for Ovarian Cancer" 
  1/1/2013
• "Oncology Fellows Core Curriculum: Fertility Preservation in Patients with Cancer" 
  1/1/2013
• "Internal Medicine Residency Program Core Curriculum Series: Overview of Gynecologic Malignancies" 
  1/1/2013
• "Gynecologic Oncology Update for the Generalist" 
  Kauai, HI - 1/1/2013
• The role of CHFR expression in ovarian cancer and response to therapy. 
  Chicago, IL - 1/1/2013
• The mTOR Pathway in Cancer 
  1/1/2012
• "Updates in Gynecologic Oncology" 
  1/1/2012
• "Internal Medicine Core Curriculum Series: Gynecologic Malignancies" 
  1/1/2011
• Small Group Leader: "Chemotherapeutic Agents Used in AML" 
  1/1/2010
• "The IGF/IGF1R Pathway in Cancer" 
  1/1/2010
• "Oncology Fellows Core Curriculum: Oncologic Emergencies" 
  1/1/2010
• Dual Inhibition of mTORC1/mTORC2 Induces Apoptosis of Mantle Cell Lymphoma by Preventing Rictor Mediated AKT Phosphorylation by Potentiating AKT2-PJLPP1 Association. 
  Orlando, FL - 1/1/2010
• OSI-027, a Dual TORC1/TORC2 Inhibitor, Induces Bim-and Puma-Mediated Apoptosis in Lymphoid Malignancy. 
  Orlando, FL - 1/1/2010
• "Fertility Preservation Counseling Patterns Among Hematology Oncology Health Care Providers" 
  1/1/2010
• Fournier's Gangrene: A Classic Case of an Uncommon Diagnosis. 
  Minneapolis, MN - 1/1/2006
• "T Cell Lymphoma Masquerading as a Flare of Multiple Sclerosis" 
  1/1/2005
• Progression of CML from Chronic Phase to Blast Crisis During Treatment with Imatnib Mesylate: A Report of Three Cases. 
  Vancouver, British Columbia, Canada - 1/1/2004
• "IL-4 and IL-13 Gene Transfer in Procine Endothelial Cells Induce Cytokine Production and Protection from Apoptosis and Human Complement." 
  Glasgow, England - 1/1/2003
• IL-4 and IL-13 Gene Transfer in Porcine Endothelial Cells Induce Cytokine Production and Protection from Apoptosis and Human Complement. 
  Minneapolis, MN - 1/1/2003
• Join now to see all